NexImmune Inc (NEXI)
0.3235
+0.10
(+46.31%)
USD |
OTCM |
Nov 14, 15:14
NexImmune Shareholders Equity (Quarterly): 0.9205M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.9205M |
| March 31, 2024 | 2.967M |
| December 31, 2023 | 3.510M |
| September 30, 2023 | 8.254M |
| June 30, 2023 | 17.00M |
| March 31, 2023 | 23.58M |
| December 31, 2022 | 32.30M |
| September 30, 2022 | 47.72M |
| June 30, 2022 | 55.85M |
| Date | Value |
|---|---|
| March 31, 2022 | 70.39M |
| December 31, 2021 | 83.76M |
| September 30, 2021 | 97.11M |
| June 30, 2021 | 109.91M |
| March 31, 2021 | 120.46M |
| December 31, 2020 | -15.75M |
| September 30, 2020 | -9.234M |
| December 31, 2019 | 10.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.75M
Minimum
Dec 2020
120.46M
Maximum
Mar 2021
38.79M
Average
23.58M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.861M |
| Total Liabilities (Quarterly) | 4.941M |